Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
80

Summary

Conditions
Gout
Type
Interventional
Phase
Not Applicable
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Diagnostic

Participation Requirements

Age
Between 18 years and 80 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03162341
Collaborators
Horizon Pharma Rheumatology LLC
Investigators
Study Director: Tristan Pascart, MD Hospital Group of the Catholic Institute of Lille Principal Investigator: Sébastien Ottaviani, MD Bichat Hospital of Paris Principal Investigator: Pascal Richette, MD PhD Lariboisiere Hospital of Paris